Frontage

Frontage Laboratories,Inc., a full service early-stage contract research organization (CRO) with 14 locations in the USA and China, has been assisting global biopharmaceutical companies in their drug development efforts since 2001.

Spanning from discovery through late-stage development, Frontage offers small and large molecule product development services including:

• DMPK
• Preclinical Safety and Toxicology
• Bioanalytical Services for Small and Large Molecule and Biomarkers
• CMC
• Early Stage Clinical Services
• Biometrics and Regulatory Support

These product development services have enabled many innovator, generic and consumer health companies of all sizes to file IND, NDA, ANDA, BLA and 505(b)(2) submissions in global markets allowing for successful development of important therapies and products for patients.

We are committed to providing rigorous scientific expertise to ensure the highest quality and compliance.  We successfully assist clients to advance hundreds of molecules through development to commercial launch in global markets.